The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
PRVA · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
BIIB · Healthcare · Narrow moat
On the watchlist
The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
| Measure | PRVA | BIIB | ROK | FTLF |
|---|---|---|---|---|
| Moat Score (0–100) | 67 (highest) | 67 (highest) | 67 (highest) | 66 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 80 (highest) | 32 | 39 | 55 |
| Pricing power | — | 96 (highest) | 69 | 62 |
| Returns on capital | 26 | 100 (highest) | 100 (highest) | 96 |
| Balance-sheet safety | 100 (highest) | — | 59 | 36 |
| Capital allocation | 60 | 40 | 68 | 80 (highest) |
| 1642% above value if growth stopped today | 60% above value if growth stopped today | 313% above value if growth stopped today | 31% above value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $2.8B | $34.2B | $47.9B | $78.8M |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |